Lifestyle interventions in nonalcoholic fatty liver disease
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in close association with metabolic irregularities. Between 2016 and 2019, the global prevalence among adults was reported as 38% and among children and adolescents it was about 10%. NAFLD can be progressive and is associated with increased mortality from cardiovascular disease, extrahepatic cancers and liver complications. Despite these numerous adverse outcomes, no pharmacological treatments currently exist to treat nonalcoholic steatohepatitis, the progressive form of NAFLD. Therefore, the main treatment is the pursuit of a healthy lifestyle for both children and adults, which includes a diet rich in fruits, nuts, seeds, whole grains, fish and chicken and avoiding overconsumption of ultra-processed food, red meat, sugar-sweetened beverages and foods cooked at high heat. Physical activity at a level where one can talk but not sing is also recommended, including leisure-time activities and structured exercise. Avoidance of smoking and alcohol is also recommended. Policy-makers, community and school leaders need to work together to make their environments healthy by developing walkable and safe spaces with food stores stocked with culturally appropriate and healthy food items at affordable prices as well as providing age-appropriate and safe play areas in both schools and neighbourhoods.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Individuals with lean MASLD show milder features of MASLD-related complications as compared to people with MASLD and higher BMI but have a greater prevalence of metabolic alterations, such as dyslipidemia, arterial hypertension, type 2 diabetes, increased visceral fat and decreased muscle mass.
“Individuals with lean MASLD show milder features of MASLD-related complications as compared to people with MASLD and higher body mass index (BMI) [37] but have a greater prevalence of metabolic alterations, such as dyslipidemia, arterial hypertension, type 2 diabetes, increased visceral fat and decreased muscle mass [14].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [14]
The Mediterranean diet advocates the reduction of sugars and refined carbohydrates, saturated fat, ultra-processed foods, and red and processed meat, which are all related to MASLD risk in observational studies.
“Notably, the Mediterranean diet advocates the reduction of sugars and re fi ned carbohydrates, saturated fat, ultra-processed foods, and red and processed meat, which are all related to MASLD risk in observational studies. 104,284,299 -301”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [284]
There is limited data on long-term dietary interventions in MASLD since study durations range from 2-24 months.
“There is limited data on long-term dietary interventions in MASLD since study durations range from 2-24 months. 283 -285”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [284]
The citation lists haven’t been fetched yet
References 195 · Cited by 281
- Authors
- Younossi, Z. M., Zelber-Sagi, S., Henry, L., & Gerber, L. H.
- Affiliations
- Inova Health System (US)
- Corresponding author
- Younossi, Zobair M.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2023-07-04
- Volume
- 20
- Issue
- 11
- Pages
- 708-722
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4383066372
- Cited by
- 281
- References
- 195
- Citations by year
- 2026: 67 · 2025: 112 · 2024: 90 · 2023: 12
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- non-alcoholic fatty liver disease, lifestyle intervention, nonalcoholic steatohepatitis, diet, physical activity, ultra-processed foods, sugar-sweetened beverages, cardiovascular disease, extrahepatic cancer, childhood obesity, healthy food access
- MeSH terms
- Red Meat, Adolescent, Adult, Animals, Child, Diet, Humans, Life Style, Exercise, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review